冯森玲;梁宝莹;谭湘萍;梅峥嵘;袁中文;
FENG Senling;LIANG Baoying;TAN Xiangping;MEI Zhengrong;YUAN Zhongwen;Department of Pharmacy,Key Laboratory for Major Obstetric Diseases of Guangdong Province,the Third Affiliated Hospital of Guangzhou Medical University;Department of Dermatology,the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangdong Provincial Hospital of Traditional Chinese Medicine;

• 1:广州医科大学附属第三医院药学部广东省产科重大疾病重点实验室
• 2:广州中医药大学第二附属医院广东省中医院皮肤科

摘要(Abstract)：

目的探究尼卡地平逆转耐奥沙利铂结肠癌细胞HCT116/L耐药的疗效及其机制。方法采用MTT法分别检测尼卡地平和奥沙利铂在HCT116/L和HCT116细胞上的药敏性,并检测尼卡地平能否逆转奥沙利铂耐药。采用流式细胞仪(FCM)检测HCT116/L细胞凋亡和细胞内罗丹明-123的浓度。结果奥沙利铂在耐药细胞HCT116/L及亲本细胞HCT116的IC50分别为(20.07±1.32)μM,(0.65±0.05)μM,具有明显的耐药差异性(P<0.001),耐药指数(RI)为(30.86±2.21)。尼卡地平在耐药细胞HCT116/L及亲本细胞HCT116的IC50分别为(22.76±1.52)μM,(21.65±1.35)μM,两者之间的细胞毒性没有统计学差异。FCM法检测结果显示尼卡地平和奥沙利铂联用能显著增加耐药细胞株凋亡率(P<0.001),且能明显增加耐药细胞HCT116/L内罗丹明-123的浓度。结论尼卡地平能增强HCT116/L细胞对奥沙利铂的敏感性,其逆转耐药的作用与诱导耐药细胞HCT116/L凋亡,影响转运蛋白P-gp的功能有关。
OBJECTIVE To study the mechanism of nicardipine reverse cell resistance in HCT116/L cells,and to detect the effect of combination of nicardipine and oxaliplatin on HCT116/L cells. METHODS MTT method was used to detect the drug sensitivity of nicardipine and oxaliplatin on HCT116/L and HCT116 cells,and to detect whether nicardipine could reverse oxaliplatin resistance. Flow cytometry( FCM) was used to detect the apoptosis of HCT116/L cells and the content of Rho123 in HCT116/L cells.RESULTS The IC50 of oxaliplatin in drug-resistant cells HCT116/L and parental cells HCT116 were( 20.07± 1.32) μM and( 0.65±0.05) μM,respectively,showing significant differences in drug resistance( P<0.001).And the resistance index( RI) was 30.86± 2.21.The IC50 of nicardipine in HCT116/L and HCT116 were( 22.76±1.52) μM and( 21.65±1.35) μM,respectively. There was no statistical difference in cytotoxicity between the two cells. FCM assay showed that nicardipine combining with oxaliplatin could significantly increase the apoptosis rate of HCT116/L( P<0.001),and significantly increase the content of Rho123 in drug-resistant cells HCT116/L.CONCLUSION Nicardipine can reverse the resistance of HCT116/L cells to oxaliplatin. The effect of reversing resistance are related to induce the apoptosis of HCT116/L cells and affect the function of the P-gp transport protein.

关键词(KeyWords)： 尼卡地平;奥沙利铂;人结肠癌细胞;耐药
nicardipine;oxaliplatin;HCT116/L;drug resistance

Abstract:

Keywords:

基金项目(Foundation): 广东省基础与应用基础研究基金区域联合基金(2019A1515111109);; 广东省医院药学研究基金(2020A28);; 广州医科大学附属第三医院2019年度博士启动科研项目(2019B03);; 广东省医学科学技术研究基金项目(A2020365);; 广东省中医药局科研项目(20201213)

作者(Author): 冯森玲;梁宝莹;谭湘萍;梅峥嵘;袁中文;
FENG Senling;LIANG Baoying;TAN Xiangping;MEI Zhengrong;YUAN Zhongwen;Department of Pharmacy,Key Laboratory for Major Obstetric Diseases of Guangdong Province,the Third Affiliated Hospital of Guangzhou Medical University;Department of Dermatology,the Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangdong Provincial Hospital of Traditional Chinese Medicine;

Email:

DOI:

参考文献(References)：

• [1]杨畅，范兰兰，黄旭．结肠癌药物预防的研究进展[J]．当代化工研究，2019(6):181-182．
• [2]井元英．结肠癌采用奥沙利铂联合化疗治疗的疗效探究[J]．中国实用医药，2019,14(33):113-114．
• [3]田春阳，刘晓政，范军朝．奥沙利铂联合柔红霉素诱导结肠癌细胞系HT-29凋亡[J]．基础医学与临床，2020,40(3):310-314．
• [4]Dong J,Qin Z,Zhang W D,et al.Medicinal chemistry strategies to discover P-glycoprotein inhibitors:An update[J].Drug Resist Updat,2020,49:100681．
• [5]Alnajjar L M,Bulatova N R,Darwish R M.Evaluation of four calcium channel blockers as fluconazole resistance inhibitors in Candida glabrata[J].J Glob Antimicrob Resist,2018,14:185-189．
• [6]杨军，石欣，严伟，等．尼卡地平对胰腺癌Patu8988株培美曲塞耐药的逆转作用[J]．世界华人消化杂志，2010,18(2):132-136．
• [7]刘伟，只达石．尼卡地平和威猛联合逆转C6/VM-26耐药并诱导凋亡研究[J]．中华神经外科疾病研究杂志，2005,4(6):512-515．
• [8]刘伟，魏盾，孙续腾．尼卡地平和VM-26逆转C6/VM-26耐药性研究[J]．北华大学学报(自然科学版)，2002,3(3):206-209．
• [9]陈贤鸿，王炳芳，陈锡美．尼卡地平抑制肝癌耐药细胞增殖的研究[J]．铁道医学，2001,29(3):149-151．
• [10]Palmeira A,Sousa E,Vasconcelos M H,et al.Three decades of P-gp inhibitors:Skimming through several generations and scaffolds[J].Curr Med Chem,2012,19(13):1946-2025．
• [11]Shi Y Y,Song Z J.Applications for nicardipine in preparing antilung cancer products[J].US Patent App,2018．
• [12]Feng S L,Yuan Z W,Yao X J,et al.Tangeretin,a Citrus pentamethoxyflavone,antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function[J].Pharmacol Res,2016,110:193-204．
• [13]Feng S L,Luo H B,Cai L,et al.Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter:In vitro and in vivo study[J].J Ginseng Res,2020,44(2):247-257．
• [14]Feng S,Zhou H,Wu D,et al.Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer:Total synthesis and discovery of potent MDR reversal agents[J].Acta Pharm Sin B,2020,10(2):327-343．
• [15]李中辉，董旺，陈敏，等．大黄素下调ILK/PI3K/Akt信号通路抑制结肠癌CACO-2细胞增殖的机制研究[J]．今日药学，2020,30(2):116-120.